PubMed HealthSearch

Biomedical subjects

H Scheu

Publications and source records attributed to H Scheu.

At least 19 recordsLinked to original sources

[Factors determining compliance in hypertensive patients].

The influence of various demographic, disease-related and therapeutic factors on compliance has been investigated in 110 patients with hypertension, heart failure or edema. While demographic factors such as age, sex, socioeconomic status, marital status and smoking habits, scarcely influenced drug adherence, duration of therapy showed the greatest compliance-lowering effect. In the 27 hospitalized patients compliance decreased in 3.2 weeks from 92.6% to 75% and in 83 outpatients from 83% to 56% in 17.8 weeks. Totally mean compliance of hospitalized patients was higher (86.9%) than in outpatients (79.7%). The percentage of fully compliant patients was also greater (74%) in hospitalized patients than in outpatients (54.2%). Patients with symptomatic diagnoses complied better than asymptomatic patients: Mean compliance rate was 87% (n = 17) in outpatients with heart failure or edema and 77.3% (n = 66) in hypertensive outpatients. Hypertensives with symptoms due to other diseases also showed a higher compliance (80%) than those with asymptomatic diagnoses (71.1%). New symptoms during therapy and side effects of the antihypertensive treatment decreased the percentage of compliers to 64% and 59% respectively. On the other hand, the severity of hypertension had no effect on drug adherence. Patients with systolic blood pressure values between 140 and less than 180 mm Hg showed an identical compliance (79.8%; n = 47) to those with systolic values greater than 180 mm Hg (79.9% n = 60).

Age Factors

[Compliance in hypertensive patients and patients with cardiac insufficiency].

In the present study the compliance or drug-adherence of 83 patients with hypertension (n = 66), heart failure (n = 14) or edema of non-cardiac origin (n = 3) was investigated by the urine fluorescence method over an observation period of 17.8 +/- 15.1 weeks. Mean compliance rate of all patients was 79.7%. Individual drug-adherence ranged from 0 to 100%. Half of the patients (54.2%; n = 45) had positive urine samples in all investigations performed. A quarter (25.3%; n = 21) were compliant in over 50%, whereas in 14.5% (n = 12) the drug could be detected in the urine in only 10 to 50% of the tests and in 6% (n = 5) in less than 10%. The 17 symptomatic patients (patients with heart failure and/or edemas) showed a slightly better compliance (87.0%) than patients with hypertension, who had positive urine samples in 77.3 +/- 30.1% of tests. However, the difference observed was not statistically significant. During treatment a decrease in compliance from 82% at the first visit to 73% and 75% respectively at the second and third could be observed. Finally, at the fourth and fifth consultation only 62.2% and 56% respectively of the patients had positive urine samples. Our results show a good compliance rate in our patients as compared to American studies. During treatment a continuous decrease in compliance could be observed. Our results indicate that the duration of treatment seems to be an important determinant for the patient's drug-adherence. Therefore, it appears necessary to perform compliance-improving strategies as early as after the first follow-up visits.

Adult